GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Telescope Innovations Corp (OTCPK:TELIF) » Definitions » Debt-to-Asset

TELIF (Telescope Innovations) Debt-to-Asset : 0.38 (As of May. 2024)


View and export this data going back to 2022. Start your Free Trial

What is Telescope Innovations Debt-to-Asset?

Telescope Innovations's Short-Term Debt & Capital Lease Obligation for the quarter that ended in May. 2024 was $0.07 Mil. Telescope Innovations's Long-Term Debt & Capital Lease Obligation for the quarter that ended in May. 2024 was $1.41 Mil. Telescope Innovations's Long-Term Debt & Capital Lease ObligationTotal Assets for the quarter that ended in May. 2024 was $3.86 Mil. Telescope Innovations's debt to asset for the quarter that ended in May. 2024 was 0.38.


Telescope Innovations Debt-to-Asset Historical Data

The historical data trend for Telescope Innovations's Debt-to-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Telescope Innovations Debt-to-Asset Chart

Telescope Innovations Annual Data
Trend Dec19 Dec20 Aug21 Aug22 Aug23
Debt-to-Asset
2.13 2.75 - - -

Telescope Innovations Quarterly Data
Sep19 Dec19 Mar20 Sep20 Dec20 Mar21 Aug21 Nov21 Feb22 May22 Aug22 Nov22 Feb23 May23 Aug23 Nov23 Feb24 May24
Debt-to-Asset Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - 0.36 0.37 0.38

Competitive Comparison of Telescope Innovations's Debt-to-Asset

For the Biotechnology subindustry, Telescope Innovations's Debt-to-Asset, along with its competitors' market caps and Debt-to-Asset data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Telescope Innovations's Debt-to-Asset Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Telescope Innovations's Debt-to-Asset distribution charts can be found below:

* The bar in red indicates where Telescope Innovations's Debt-to-Asset falls into.



Telescope Innovations Debt-to-Asset Calculation

Debt to Asset measures the financial leverage a company has.

Telescope Innovations's Debt-to-Asset for the fiscal year that ended in Aug. 2023 is calculated as

Telescope Innovations's Debt-to-Asset for the quarter that ended in May. 2024 is calculated as

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Telescope Innovations  (OTCPK:TELIF) Debt-to-Asset Explanation

In the calculation of Debt-to-Asset, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by Total Assets.


Telescope Innovations Debt-to-Asset Related Terms

Thank you for viewing the detailed overview of Telescope Innovations's Debt-to-Asset provided by GuruFocus.com. Please click on the following links to see related term pages.


Telescope Innovations Business Description

Traded in Other Exchanges
Address
301 – 2386 East Mall, Vancouver, BC, CAN, V6T 1Z3
Telescope Innovations Corp is a technology company that intends to focus on development as a Contract Research Organization (CRO) to develop intellectual property, contract research, and building automation products. The Company has one operating segment that generates revenues from two revenue streams, contract research services and sale of automation products.